⌂
Home
◈
Markets
▦
Screener
📈
Tools
◎
Portfolio
Skip to content
DFM General
5,851.39
−0.27%
FTSE ADX
9,783.24
−0.26%
TASI
10,123.62
−0.65%
QE Index
8,632.66
−0.01%
S&P 500
7,706.88
+0.62%
Nasdaq 100
29,616.85
+1.47%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
165,966.09
−0.27%
DFM:EMIRATESNBD
AED 31.50
−0.25%
ADX:IHC
AED 352.00
−0.17%
SAU:2222
SAR 25.80
+0.00%
DSMD:QNBK
QAR 15.66
+2.29%
NAS:NVDA
$217.98
+1.80%
NYSE:TSM
$423.13
+2.55%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 299.47
+0.12%
Gold
$4,142.46
−0.55%
Brent
$109.43
−0.35%
BTC
$81,956.00
−0.07%
ETH
$2,400.12
−0.30%
DFM General
5,851.39
−0.27%
FTSE ADX
9,783.24
−0.26%
TASI
10,123.62
−0.65%
QE Index
8,632.66
−0.01%
S&P 500
7,706.88
+0.62%
Nasdaq 100
29,616.85
+1.47%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
165,966.09
−0.27%
DFM:EMIRATESNBD
AED 31.50
−0.25%
ADX:IHC
AED 352.00
−0.17%
SAU:2222
SAR 25.80
+0.00%
DSMD:QNBK
QAR 15.66
+2.29%
NAS:NVDA
$217.98
+1.80%
NYSE:TSM
$423.13
+2.55%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 299.47
+0.12%
Gold
$4,142.46
−0.55%
Brent
$109.43
−0.35%
BTC
$81,956.00
−0.07%
ETH
$2,400.12
−0.30%
☰
Markets
▼
Stock markets
🇦🇪
UAE
DFM · ADX · DFM General
Closed
🇸🇦
Saudi Arabia
Tadawul · TASI
Closed
🇶🇦
Qatar
QSE · QE General
Closed
🇺🇸
United States
Nasdaq · NYSE · S&P 500
Open
🇮🇳
India
NSE · BSE · Nifty 50
Closed
🇵🇰
Pakistan
PSX · KSE-100
Closed
Other assets
₿
Crypto
Ranked by volume · 24/7
🥇
Gold, FX & economy
Dubai gold, AED crosses, rates
◫
ETFs
Index, sector and gold funds
Explore
▦
Market map
Every market as a heatmap
📅
Calendar & IPOs
Earnings, dividends, listings, releases
⌁
Options flow · Ownership · Politics
US filings and tapes
Screener
▼
⚲
Stock screener
All six markets, one row per company
★
Ready-made screens
Starting points with a point of view
📁
My saved screens
Saved rules with alerts on new matches
⇄
Compare
Up to five, side by side
Crypto
Tools
▼
📈
Charting
Drawings, indicators, replay
▶
Strategy Maker
Write a rule, test it on history
⇄
Compare
Side by side
🔔
Alerts
Price, earnings, screens, strategies
News
Portfolio
⌕
AED
USD
SAR
QAR
INR
PKR
GBP
EUR
KWD
OMR
BHD
☆
♢
☾
Sign in
Create account
👤
Merck & Co Inc · News · TradingHolo
Markets
›
United States
› NYSE
› MRK
M
Merck & Co Inc
NYSE:MRK
Healthcare
CBOE:SPESG
DJ:DJA
$143.91
−1.40%
Live
In session · ≈
AED 528.51
· Market cap
$355.05B
· Next earnings
Thu 29 Oct
☆
Watch
🔔
Alert
⇄
Compare
▶
Test a strategy
✦
AI read
Overview
Chart
Financials
Valuation
Forecasts
Dividends
Ownership
Options
Shorts
News
Profile
MRK news
Headlines tagged to this company
DO
Merck Price Target Cut to $145.00/Share From $150.00 by RBC Capital
Dow Jones Newswires · 7 d ago
TR
RBC Capital maintains Sector Perform rating on Merck & Co, $145 price target
TradingView · 7 d ago
SE
Merck's experimental eye drug meets goal in trial, but raises safety concerns
Seeking Alpha · 8 d ago
RE
Merck Presents One-Year Results From The Pivotal Phase 2B/3 Brunello Study Evaluating Remigromig
Reuters · 9 d ago
BU
Merck Presents One-Year Results from the Pivotal Phase 2b/3 BRUNELLO Study Evaluating Remigromig, a Tri-specific Agonist of the Wingless-related Integration Site (Wnt) Pathway, in Adults with Diabetic Macular Edema at AAO 2026
BusinessWire · 9 d ago
SE
Hospital group files lawsuit to stop 340B rebate pilot again
Seeking Alpha · 9 d ago
ST
PFE, LLY, MRK Stocks In Focus: Cantor Raises Price Targets On Pharma Behemoths, But Flags Growth Concerns For Pfizer
Stocktwits · 11 d ago
SE
Google reveals Gemini Agent ready to work for enterprises from single box prompt
Seeking Alpha · 11 d ago
TR
Merck & Company, Inc. Stock 12‑Month Price Target Raised to $157.48, Implies 10% Upside
TradingView · 11 d ago
DO
Merck Price Target Raised to $145.00/Share From $120.00 by Cantor Fitzgerald
Dow Jones Newswires · 11 d ago
RE
Halozyme wins court order to block Merck's injected Keytruda in select European markets
Reuters · 12 d ago
DO
Merck's Keytruda Is Dealt a Legal Setback. It's Good News for This Biotech Stock. — Barrons.com
Dow Jones Newswires · 12 d ago
DO
Halozyme Wins Injunction Against Merck in Keytruda Patent Case — Update
Dow Jones Newswires · 12 d ago
DO
Merck Price Target Cut to $177.00/Share From $179.00 by Morgan Stanley
Dow Jones Newswires · 12 d ago
SE
15 dividend stocks beating the S&P 500 as markets sit near record highs
Seeking Alpha · 12 d ago
DO
Halozyme Granted Another Injunction Against Merck in Keytruda Patent Case
Dow Jones Newswires · 12 d ago
DO
Tempus Enters Multiyear Collaboration With Moderna, Merck Aimed at Commercializing Cancer Drug
Dow Jones Newswires · 12 d ago
← Previous
More news →